Swedish Pharmaceuticals & Biotech Big Green Snowflakes

Biotage

Market Cap: SEK 11.4b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

Camurus

Market Cap: SEK 30.2b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

BioArctic

Market Cap: SEK 16.2b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Lipigon Pharmaceuticals

Market Cap: SEK 13.1m

Develops drugs for lipid related diseases in Sweden.

Bonesupport Holding

Market Cap: SEK 16.2b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BioGaia

Market Cap: SEK 10.1b

A healthcare company, provides probiotic products worldwide.

Saniona

Market Cap: SEK 1.3b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Elicera Therapeutics

Market Cap: SEK 306.3m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

AcouSort

Market Cap: SEK 69.8m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

Swedish Orphan Biovitrum

Market Cap: SEK 104.8b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Ascelia Pharma

Market Cap: SEK 496.6m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Nanologica

Market Cap: SEK 91.9m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

Vitrolife

Market Cap: SEK 20.8b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

NextCell Pharma

Market Cap: SEK 79.7m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

SynAct Pharma

Market Cap: SEK 755.7m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Biosergen

Market Cap: SEK 147.5m

A biotech company, develops antifungal products.

Mendus

Market Cap: SEK 265.6m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Cinclus Pharma Holding

Market Cap: SEK 695.3m

A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.

Swedencare

Market Cap: SEK 6.5b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Biovica International

Market Cap: SEK 76.5m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.

Guard Therapeutics International

Market Cap: SEK 356.0m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Moberg Pharma

Market Cap: SEK 435.9m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Vicore Pharma Holding

Market Cap: SEK 2.0b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Initiator Pharma

Market Cap: SEK 216.2m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Sprint Bioscience

Market Cap: SEK 43.2m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Corline Biomedical

Market Cap: SEK 244.9m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Xbrane Biopharma

Market Cap: SEK 362.8m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 64.4m

A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, as well as opioid overdose and anaphylactic shock.

Genovis AB (publ.)

Market Cap: SEK 1.7b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Devyser Diagnostics

Market Cap: SEK 1.8b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Active Biotech

Market Cap: SEK 379.5m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

ExpreS2ion Biotech Holding

Market Cap: SEK 60.5m

A biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally.

AlzeCure Pharma

Market Cap: SEK 283.4m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

MedCap

Market Cap: SEK 6.4b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Scandion Oncology

Market Cap: SEK 4.0m

A clinical-stage biotechnology company, develops medicines for the treatment of cancer.

Medivir

Market Cap: SEK 187.1m

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.